- Home
- Publications
- Publication Search
- Publication Details
Title
Retargeting Strategies for Oncolytic Herpes Simplex Viruses
Authors
Keywords
-
Journal
Viruses-Basel
Volume 8, Issue 3, Pages 63
Publisher
MDPI AG
Online
2016-02-26
DOI
10.3390/v8030063
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Engineered adenoviruses combine enhanced oncolysis with improved virus production by mesenchymal stromal carrier cells
- (2015) Katharina Hammer et al. INTERNATIONAL JOURNAL OF CANCER
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of miRNA Response Sequences to Block Off-target Replication and Increase the Safety of an Unattenuated, Glioblastoma-targeted Oncolytic HSV
- (2015) Lucia Mazzacurati et al. MOLECULAR THERAPY
- Dissociation of HSV gL from gH by αvβ6- or αvβ8-integrin promotes gH activation and virus entry
- (2015) Tatiana Gianni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases
- (2015) Valerio Leoni et al. Oncotarget
- From virotherapy to oncolytic immunotherapy: where are we now?
- (2015) Robert S Coffin Current Opinion in Virology
- The Engineering of a Novel Ligand in gH Confers to HSV an Expanded Tropism Independent of gD Activation by Its Receptors
- (2015) Valentina Gatta et al. PLoS Pathogens
- Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children
- (2015) Timothy P Cripe et al. Molecular Therapy-Oncolytics
- Stem Cells Loaded With Multimechanistic Oncolytic Herpes Simplex Virus Variants for Brain Tumor Therapy
- (2014) Matthias Duebgen et al. JNCI-Journal of the National Cancer Institute
- Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus
- (2014) Elizabeth Ilett et al. MOLECULAR THERAPY
- From Scourge to Cure: Tumour-Selective Viral Pathogenesis as a New Strategy against Cancer
- (2014) Carolina S. Ilkow et al. PLoS Pathogens
- Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity
- (2013) A. Castleton et al. BLOOD
- DARPin-targeting of Measles Virus: Unique Bispecificity, Effective Oncolysis, and Enhanced Safety
- (2013) Katrin Friedrich et al. MOLECULAR THERAPY
- New viruses for cancer therapy: meeting clinical needs
- (2013) Tanner S. Miest et al. NATURE REVIEWS MICROBIOLOGY
- Regulation of Herpes Simplex Virus gB-Induced Cell-Cell Fusion by Mutant Forms of gH/gL in the Absence of gD and Cellular Receptors
- (2013) D. Atanasiu et al. mBio
- Preclinical Therapy of Disseminated HER-2+ Ovarian and Breast Carcinomas with a HER-2-Retargeted Oncolytic Herpesvirus
- (2013) Patrizia Nanni et al. PLoS Pathogens
- Vitamin D3-Inducible Mesenchymal Stem Cell-Based Delivery of Conditionally Replicating Adenoviruses Effectively Targets Renal Cell Carcinoma and Inhibits Tumor Growth
- (2012) Wan-Chi Hsiao et al. MOLECULAR PHARMACEUTICS
- Replication-competent Herpes Simplex Virus Retargeted to HER2 as Therapy for High-grade Glioma
- (2012) Eleonora Gambini et al. MOLECULAR THERAPY
- Effective Treatment of an Orthotopic Xenograft Model of Human Glioblastoma Using an EGFR-retargeted Oncolytic Herpes Simplex Virus
- (2012) Hiroaki Uchida et al. MOLECULAR THERAPY
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Viral and cellular contributions to herpes simplex virus entry into the cell
- (2012) Gabriella Campadelli-Fiume et al. Current Opinion in Virology
- Fusing structure and function: a structural view of the herpesvirus entry machinery
- (2011) Sarah A. Connolly et al. NATURE REVIEWS MICROBIOLOGY
- Structure of Herpes Simplex Virus Glycoprotein D Bound to the Human Receptor Nectin-1
- (2011) Paolo Di Giovine et al. PLoS Pathogens
- Carrier cell-based delivery of replication-competent HSV-1 mutants enhances antitumor effect for ovarian cancer
- (2010) S Fujiwara et al. CANCER GENE THERAPY
- Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter
- (2010) S L Longo et al. CANCER GENE THERAPY
- A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer
- (2010) A Nakao et al. CANCER GENE THERAPY
- Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck
- (2010) K. J. Harrington et al. CLINICAL CANCER RESEARCH
- Directing systemic oncolytic viral delivery to tumors via carrier cells☆
- (2010) Hiroshi Nakashima et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors
- (2010) Pelagia Foka et al. JOURNAL OF GENE MEDICINE
- Transcriptional and Translational Dual-regulated Oncolytic Herpes Simplex Virus Type 1 for Targeting Prostate Tumors
- (2010) Cleo YF Lee et al. MOLECULAR THERAPY
- Crystal structure of the conserved herpesvirus fusion regulator complex gH–gL
- (2010) Tirumala K Chowdary et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structure of a core fragment of glycoprotein H from pseudorabies virus in complex with antibody
- (2010) M. Backovic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
- (2009) Neil N. Senzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy
- (2009) Candice Willmon et al. MOLECULAR THERAPY
- Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells
- (2009) L. Menotti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice
- (2008) Y Kulu et al. CANCER GENE THERAPY
- Cell carriers to deliver oncolytic viruses to sites of myeloma tumor growth
- (2008) A Munguia et al. GENE THERAPY
- Potential for efficacy of the oncolytic Herpes simplex virus 1716 in patients with oral squamous cell carcinoma
- (2008) Alastair T. M. Mace et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Analysis of a Membrane Interacting Region of Herpes Simplex Virus Type 1 Glycoprotein H
- (2008) Stefania Galdiero et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Construction of a Fully Retargeted Herpes Simplex Virus 1 Recombinant Capable of Entering Cells Solely via Human Epidermal Growth Factor Receptor 2
- (2008) L. Menotti et al. JOURNAL OF VIROLOGY
- A Herpes Oncolytic Virus Can Be Delivered Via the Vasculature to Produce Biologic Changes in Human Colorectal Cancer
- (2008) Yuman Fong et al. MOLECULAR THERAPY
- Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM
- (2008) James M Markert et al. MOLECULAR THERAPY
- Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
- (2008) Roberto Cattaneo et al. NATURE REVIEWS MICROBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search